A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05865496 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Sinusitis
Nasal Polyps
Polyps

Interventions

DRUG: 611
DRUG: Placebo

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.